Mackenzie Financial Corp Acquires New Holdings in Revvity, Inc. (NYSE:RVTY)

Mackenzie Financial Corp acquired a new stake in Revvity, Inc. (NYSE:RVTY) during the 4th quarter, HoldingsChannel.com reports. The fund acquired 13,887 shares of the company’s stock, valued at approximately $1,518,000.

Other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. acquired a new position in shares of Revvity in the 3rd quarter worth approximately $1,579,487,000. Ceredex Value Advisors LLC acquired a new position in shares of Revvity in the fourth quarter worth about $108,353,000. Sumitomo Mitsui Trust Holdings Inc. acquired a new stake in shares of Revvity during the fourth quarter worth approximately $33,568,000. Boston Trust Walden Corp acquired a new stake in shares of Revvity during the fourth quarter worth approximately $25,154,000. Finally, KBC Group NV acquired a new stake in shares of Revvity during the third quarter worth approximately $25,301,000. Institutional investors and hedge funds own 86.65% of the company’s stock.

Revvity Stock Up 2.7 %

Shares of NYSE:RVTY opened at $103.49 on Wednesday. Revvity, Inc. has a 12 month low of $79.50 and a 12 month high of $135.67. The company’s 50-day moving average price is $104.74 and its two-hundred day moving average price is $101.49. The company has a quick ratio of 1.77, a current ratio of 2.07 and a debt-to-equity ratio of 0.40. The firm has a market cap of $12.78 billion, a P/E ratio of 18.82, a P/E/G ratio of 2.63 and a beta of 1.09.

Revvity (NYSE:RVTY) last issued its earnings results on Thursday, February 1st. The company reported $1.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.15 by $0.10. The company had revenue of $695.90 million for the quarter. Revvity had a net margin of 25.20% and a return on equity of 7.41%. As a group, research analysts forecast that Revvity, Inc. will post 4.65 EPS for the current fiscal year.

Revvity Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Friday, April 19th will be given a $0.07 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.27%. Revvity’s dividend payout ratio is 5.09%.

Wall Street Analyst Weigh In

A number of research firms have issued reports on RVTY. Stifel Nicolaus lifted their target price on shares of Revvity from $95.00 to $110.00 and gave the company a “hold” rating in a research note on Friday, February 2nd. Raymond James upped their target price on shares of Revvity from $106.00 to $127.00 and gave the company an “outperform” rating in a research note on Friday, February 2nd. KeyCorp upped their target price on shares of Revvity from $110.00 to $126.00 and gave the company an “overweight” rating in a research note on Friday, February 2nd. Evercore ISI upgraded shares of Revvity from an “in-line” rating to an “outperform” rating and increased their price objective for the company from $88.00 to $125.00 in a research note on Thursday, January 4th. Finally, Barclays increased their price objective on shares of Revvity from $92.00 to $105.00 and gave the company an “equal weight” rating in a research note on Thursday, January 25th. Six analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $118.91.

Insider Activity at Revvity

In related news, insider Prahlad R. Singh sold 21,217 shares of the stock in a transaction that occurred on Monday, February 5th. The shares were sold at an average price of $104.28, for a total value of $2,212,508.76. Following the sale, the insider now directly owns 92,801 shares in the company, valued at approximately $9,677,288.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.60% of the stock is currently owned by corporate insiders.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.